Biogen
Search results
Spectrum Pharmaceuticals is an American biopharmaceutical company located in Boston, MA. It develops and markets drugs for treatments in hematology and oncology. After a deal valued at $248 million was announced in April 2023, Assertio Holdings announced that it had completed its acquisition of the Massachusetts-based company on July 31.
Apr 25, 2023 · Assertio Holdings, a specialty pharmaceutical company, will acquire Spectrum Pharmaceuticals, a biopharmaceutical company focused on oncology, in an all-stock and contingent value rights transaction. The deal is expected to be accretive to Assertio's earnings and cash flow and to enhance ROLVEDON, a novel long-acting G-CSF product, and other commercial assets.
Sep 9, 2022 · Spectrum has received an indication to decrease the incidence of infection, as manifested by febrile neutropenia, in adult patients with non-myeloid malignancies receiving myelosuppressive anti...
Sep 22, 2022 · BOSTON--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI) (“Spectrum” or the “Company”), a biopharmaceutical company focused on novel and targeted oncology therapies, today ...
Apr 25, 2023 · LAKE FOREST, Ill., and BOSTON, April 25, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (Nasdaq: ASRT) (“Assertio”), a specialty pharmaceutical company offering differentiated products to ...
Sep 22, 2022 · BOSTON--(BUSINESS WIRE)-- Spectrum Pharmaceuticals (NasdaqGS: SPPI) (“Spectrum” or the “Company”), a biopharmaceutical company focused on novel and targeted oncology therapies, today ...
Jan 5, 2022 · About Spectrum Pharmaceuticals, Inc. Spectrum Pharmaceuticals is a biopharmaceutical company focused on acquiring, developing, and commercializing novel and targeted oncology therapies....
